Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Post by Biofinderon Jun 05, 2018 1:44pm
240 Views
Post# 28127187

Plasminogen: estimated $8 Billion USD untapped WW market

Plasminogen: estimated $8 Billion USD untapped WW marketPlasminogen (Ryplazim) estimated $8 Billion USD market by 2024
 
CALCULATIONS for PLASMINOGEN (Ryplazim) VALUE:
Estimated $8 Billion USD WW market by 2024
Estimated 1 Billion outstanding shares of PLI
$8 billion (WW market)  divided by  1 billion (shares) =
= $8 USD pps  x  300,000 PLI shares = $2.4 million USD
 
Then add the estimated USD $$ value of pbi-4050 to your shares...
 
I still opine around 2020 the fireworks will begin in earnest for PLI
 
I can wait
 
gl2all

(all you fear mongers have at it:  tell mommy and daddy all about PLI’s lack of money, or their lack of partnerships, or that Ryplazim FDA approval is not already a given; you continue live your fears and I’ll continue to live the dream, isn’t early retirement grand).

 

Bullboard Posts